ATLAS / Macro Radar / Reporting / MCRB

Seres Therapeutics, Inc. (MCRB) reporting calendar

Seres Therapeutics, Inc. files periodic reports with the SEC as MCRB on Nasdaq. Atlas tracks 44 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
22 Jul 2026 – 27 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
5 May 2026
Reports on record
44

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 40 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open MCRB market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20265 May 202635 days0001193125-26-205434
10-K31 Dec 202512 Mar 202671 days0001193125-26-103276
10-Q30 Sep 20255 Nov 202536 days0001193125-25-266011
10-Q30 Jun 20256 Aug 202537 days0000950170-25-103611
10-Q31 Mar 20257 May 202537 days0000950170-25-065173
10-K31 Dec 202413 Mar 202572 days0000950170-25-038427
10-Q30 Sep 202413 Nov 202444 days0000950170-24-126018
10-Q30 Jun 202413 Aug 202444 days0000950170-24-095821
10-Q31 Mar 20248 May 202438 days0000950170-24-055159
10-K31 Dec 20235 Mar 202465 days0000950170-24-025464
10-Q30 Sep 20232 Nov 202333 days0000950170-23-057805
10-Q30 Jun 20238 Aug 202339 days0000950170-23-039439
10-Q31 Mar 20239 May 202339 days0000950170-23-019222
10-K31 Dec 20227 Mar 202366 days0000950170-23-006374
10-Q30 Sep 20222 Nov 202233 days0000950170-22-021018
10-Q30 Jun 20223 Aug 202234 days0000950170-22-014052
10-Q31 Mar 20224 May 202234 days0000950170-22-007217
10-K31 Dec 20211 Mar 202260 days0000950170-22-002435
10-Q30 Sep 202110 Nov 202141 days0000950170-21-003937
10-Q30 Jun 20213 Aug 202134 days0000950170-21-000674
10-Q31 Mar 20214 May 202134 days0001564590-21-023017
10-K31 Dec 20202 Mar 202161 days0001564590-21-010057
10-Q30 Sep 20209 Nov 202040 days0001564590-20-052273
10-Q30 Jun 202028 Jul 202028 days0001564590-20-033715
10-Q31 Mar 20207 May 202037 days0001564590-20-022457
10-K31 Dec 20192 Mar 202062 days0001564590-20-008002
10-Q30 Sep 20195 Nov 201936 days0001564590-19-040255
10-Q30 Jun 20196 Aug 201937 days0001564590-19-029069
10-Q31 Mar 20192 May 201932 days0001564590-19-015070
10-K31 Dec 20186 Mar 201965 days0001564590-19-006423
10-Q30 Sep 20188 Nov 201839 days0001564590-18-028339
10-Q30 Jun 20182 Aug 201833 days0001564590-18-018757
10-Q31 Mar 20189 May 201839 days0001564590-18-012140
10-K31 Dec 20178 Mar 201867 days0001564590-18-004830
10-Q30 Sep 20178 Nov 201739 days0001564590-17-022569
10-Q30 Jun 20173 Aug 201734 days0001564590-17-015366
10-Q31 Mar 20174 May 201734 days0001564590-17-008791
10-K31 Dec 201616 Mar 201775 days0001564590-17-004551
10-Q30 Sep 201610 Nov 201641 days0001564590-16-028938
10-Q30 Jun 201611 Aug 201642 days0001564590-16-024023

Source: SEC EDGAR company submissions for CIK 0001609809. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.